Digital health accelerator ANDHealth and biomedical commercialisation fund Brandon BioCatalyst have been awarded $50 million to launch another round of their CUREator+ BioMedTech program to support commercialisation and translation of research targeting dementia and cognitive decline. Friday’s funding announcement from Health minister Mark Butler was a part of $230 million worth of new commitments made…

The post Additional $50m for BioMedTech commercialisation program appeared first on InnovationAus.com.

This post was originally published on InnovationAus.com.